Observational studyHepatology (Baltimore, Md.)2021

Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study.

Judith van Dalem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.